A worldwide overview for hexavalent vaccines and a glimpse into Turkiye's perspective

Metehan Özen,Emin Ünüvar,Abdurrahman Yıldırım,Hakkı Akman,Süleyman Mevlitoğlu,Tamer Pehlivan
DOI: https://doi.org/10.1080/21645515.2024.2345493
2024-05-25
Human Vaccines & Immunotherapeutics
Abstract:The surge in recommended vaccinations for child's has spurred the development of combination vaccines, notably hexavalent vaccines, which provide multiple immunizations in a single dose. These vaccines offer various advantages, such as streamlining vaccination schedules, minimizing injection-related pain and exposure to preservatives, expanding vaccine coverage, and reducing administration costs. However, the intricate and expensive development of these vaccines presents substantial challenges, requiring increased investment and healthcare provider education to optimize their utilization and sustain high vaccination rates. Turkey, known for its robust vaccine coverage, strategic geographic location, and the influx of refugees, is at a critical juncture for integrating hexavalent vaccines into national programs. This transition is especially relevant given the rising vaccine hesitancy and the potential resurgence of vaccine-preventable diseases. This review assesses the deployment of hexavalent vaccines, examining their benefits and challenges through clinical trials and global experiences, with a specific emphasis on Turkiye's public health context.
immunology,biotechnology & applied microbiology
What problem does this paper attempt to address?